ID   Hela M VPS13C-KO clone 2
AC   CVCL_E6IR
SY   VPS13C(KO) HeLa clone 2
RX   PubMed=35657605;
CC   Population: African American.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:23594; VPS13C.
CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
DI   NCIt; C27677; Human papillomavirus-related endocervical adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_R965 ! HeLa M
SX   Female
AG   30Y6M
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=35657605; DOI=10.1083/jcb.202106046; PMCID=PMC9170524;
RA   Hancock-Cerutti W.F., Wu Z., Xu P., Yadavalli N.V., Leonzino M.,
RA   Tharkeshwar A.K., Ferguson S.M., Shadel G.S., De Camilli P.;
RT   "ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant
RT   mtDNA-dependent STING signaling.";
RL   J. Cell Biol. 221:e202106046.1-e202106046.19(2022).
//